← Back to headlines
Sweden Denies Alzheimer's Drug Leqembi to Patients
Swedish authorities have decided not to make a new Alzheimer's drug, Leqembi, available to patients in Sweden. The decision is based on the assessment that the drug currently lacks proven benefit for patients.
Sources
Showing 0 of 2 sources
No articles available in your preferred languages.
2 articles available in other languages below.
Coverage Timeline
First report: aftonbladet · 17 Apr, 09:41|Full coverage: 2 · 0m|Window: 0m
Left-leaningCenterRight-leaning
